Arbutus Biopharma Corp (ABUS) Revenue 2016–2025
Arbutus Biopharma Corp (ABUS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$14.1MFY2025 · since FY2016: $1.5M → $14.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.1M | +128.2% |
| FY2024 | $6.2M | -66.0% |
| FY2023 | $18.1M | -53.5% |
| FY2022 | $39.0M | +255.1% |
| FY2021 | $11.0M | +58.9% |
| FY2020 | $6.9M | +15.0% |
| FY2019 | $6.0M | +1.1% |
| FY2018 | $5.9M | -44.4% |
| FY2017 | $10.7M | +617.6% |
| FY2016 | $1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice